Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis.
Mice with targeted deletion of STAT3 in CD4(+) T-cells do not develop experimental autoimmune uveitis (EAU) or experimental autoimmune encephalomyelitis (EAE), in part, because they cannot generate pathogenic Th17 cells. In this study, we have used ORLL-NIH001, a small synthetic compound that inhibi...
Saved in:
| Main Authors: | Cheng-Rong Yu, Yun Sang Lee, Rashid M Mahdi, Narayanan Surendran, Charles E Egwuagu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0029742&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STAT3 Regulates Proliferation and Survival of CD8+ T Cells: Enhances Effector Responses to HSV-1 Infection, and Inhibits IL-10+ Regulatory CD8+ T Cells in Autoimmune Uveitis
by: Cheng-Rong Yu, et al.
Published: (2013-01-01) -
Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3)
by: Jinyun Dong, et al.
Published: (2022-12-01) -
Signal Transducer and Activator of Transcription 4 (STAT4) Association with Pituitary Adenoma
by: Greta Gedvilaite-Vaicechauskiene, et al.
Published: (2024-11-01) -
Autoimmune Uveitis. Review
by: A. N. Plekhanov, et al.
Published: (2019-03-01) -
The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitis
by: Avik Shome, et al.
Published: (2025-06-01)